These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15317027)

  • 1. Disproportionality analyses of spontaneous reports.
    Hennessy S
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):503-4. PubMed ID: 15317027
    [No Abstract]   [Full Text] [Related]  

  • 2. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; DeStefano F; Iskander JK; Haber P; Chen RT;
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):505-10. PubMed ID: 15317028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical judgment, common sense and adverse reaction reporting.
    Shapiro S
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):511-3; discussion 515-7. PubMed ID: 15317029
    [No Abstract]   [Full Text] [Related]  

  • 4. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions.
    Moore N; Thiessard F; Begaud B
    Pharmacoepidemiol Drug Saf; 2005 Apr; 14(4):285-6. PubMed ID: 15782397
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.
    Etminan M; Gill S; Fitzgerald M; Samii A
    J Clin Pharmacol; 2006 Jan; 46(1):6-9. PubMed ID: 16397278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reporting odds ratio and its advantages over the proportional reporting ratio.
    Rothman KJ; Lanes S; Sacks ST
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):519-23. PubMed ID: 15317031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative signal detection using spontaneous ADR reporting.
    Bate A; Evans SJ
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):427-36. PubMed ID: 19358225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmarketing hepatic adverse event experience with PEGylated/non-PEGylated drugs: a disproportionality analysis.
    Hauben M; Vegni F; Reich L; Younus M
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):934-41. PubMed ID: 18049161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current controversies in pharmacoepidemiology.
    Hallas J; Andersen M
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):235. PubMed ID: 16611196
    [No Abstract]   [Full Text] [Related]  

  • 11. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
    Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacoepidemiology. An unappreciated tool].
    Vasen W; Fiorentino RM
    Medicina (B Aires); 2006; 66(3):257-62. PubMed ID: 16871916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoepidemiology--a tool for public health.
    Waller P
    Pharmacoepidemiol Drug Saf; 2001; 10(2):165-72. PubMed ID: 11499856
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacoepidemiology].
    Hallas J; Sørensen HT
    Ugeskr Laeger; 2005 May; 167(20):2186-90. PubMed ID: 15987081
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection and reporting of drug-induced proarrhythmias: room for improvement.
    Darpö B
    Europace; 2007 Sep; 9 Suppl 4():iv23-36. PubMed ID: 17766321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sweden can contribute to safer drug assessment].
    Strandberg K
    Lakartidningen; 2006 Jun 8-13; 103(23):1853-5. PubMed ID: 16838598
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for good pharmacoepidemiology practices (GPP).
    ISPE
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):200-8. PubMed ID: 17868186
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
    Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for good pharmacoepidemiology practices (GPP).
    Epstein M;
    Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):589-95. PubMed ID: 15918159
    [No Abstract]   [Full Text] [Related]  

  • 20. Data mining for signals in spontaneous reporting databases: proceed with caution.
    Stephenson WP; Hauben M
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):359-65. PubMed ID: 17019675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.